Dual-targeting VEGFR1 and PD-L1 CAR-T for Cancers Patients With Pleural or Peritoneal Metastases

Conditions:   Malignant Peritoneal Effusion;   Malignant Ascites;   Serous Cavity Metastatises Intervention:   Biological: Dual-targeting VEGFR1 and PD-L1 CAR-T cells Sponsor:   Sichuan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials